A comparison of kinetics of paraprotein clearance after infusional chemotherapy versus high-dose melphalan in previously untreated patients with IgG multiple myeloma.

被引：0
|
作者：
Sirohi, B
Powles, R
Sumpter, K
Kulkarni, S
Singhal, S
Bhagwati, N
Horton, C
Saso, R
Mehta, J
Treleaven, J
机构：
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4631
引用
收藏
页码：314B / 314B
页数：1
相关论文
共 50 条
  • [31] High dose sequential chemotherapy and autologous peripheral stem cell transplantation in patients with previously treated or untreated multiple myeloma
    Kuhlmann, S
    Fossa, A
    Wrzeciono, T
    Kasper, C
    Welt, A
    Seeber, S
    Nowrousian, MR
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 352 - 353
  • [32] Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
    C Dumontet
    S Landi
    T Reiman
    T Perry
    A Plesa
    I Bellini
    R Barale
    L M Pilarski
    J Troncy
    S Tavtigian
    F Gemignani
    Bone Marrow Transplantation, 2010, 45 : 1316 - 1324
  • [33] Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy
    Mateos, Maria-Victoria
    Bringhen, Sara
    Richardson, Paul G.
    Jose Lahuerta, Juan
    Larocca, Alessandra
    Oriol, Albert
    Boccadoro, Mario
    Garcia-Sanz, Ramon
    Di Raimondo, Francesco
    Esseltine, Dixie-Lee
    van de Velde, Helgi
    Desai, Avinash
    Londhe, Anil
    San Miguel, Jesus F.
    Palumbo, Antonio
    HAEMATOLOGICA, 2014, 99 (06) : 1114 - 1122
  • [34] Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
    Dumontet, C.
    Landi, S.
    Reiman, T.
    Perry, T.
    Plesa, A.
    Bellini, I.
    Barale, R.
    Pilarski, L. M.
    Troncy, J.
    Tavtigian, S.
    Gemignani, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1316 - 1324
  • [35] Outcome of patients with multiple myeloma and hypotension during high-dose chemotherapy
    Biran, Noa
    Sehgal, Priya
    Sahni, Gagan
    Doucette, John
    Chari, Ajai
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : E125 - E127
  • [36] Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation
    Martino, Massimo
    Gori, Mercedes
    Porto, Gaetana
    Pellicano, Maria
    Santoro, Ludovica
    Verduci, Chiara
    Canale, Filippo Antonio
    Loteta, Barbara
    Moscato, Tiziana
    Alati, Caterina
    Ieracitano, Maria Consuelo
    Cuzzocrea, Amelia
    Altomonte, Maria
    Florenzano, Maria Teresa
    Morabito, Antonella
    Irrera, Giuseppe
    Naso, Virginia
    Pugliese, Marta
    Console, Giuseppe
    Ferreri, Anna
    Imbalzano, Lucrezia
    Tripepi, Giovanni
    Pitino, Annalisa
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1915 - 1925
  • [37] Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation
    Massimo Martino
    Mercedes Gori
    Gaetana Porto
    Maria Pellicano
    Ludovica Santoro
    Chiara Verduci
    Filippo Antonio Canale
    Barbara Loteta
    Tiziana Moscato
    Caterina Alati
    Maria Consuelo Ieracitano
    Amelia Cuzzocrea
    Maria Altomonte
    Maria Teresa Florenzano
    Antonella Morabito
    Giuseppe Irrera
    Virginia Naso
    Marta Pugliese
    Giuseppe Console
    Anna Ferreri
    Lucrezia Imbalzano
    Giovanni Tripepi
    Annalisa Pitino
    Annals of Hematology, 2023, 102 : 1915 - 1925
  • [38] The correlation between the kinetics of peripheral blood counts and the response to treatment after high-dose melphalan with stem cell support in multiple myeloma patients
    Grisariu, Sigal
    Halfin, Sasha
    Gatt, Moshe
    Vainstein, Vlademir
    Avni, Batia
    BONE MARROW TRANSPLANTATION, 2019, 54 : 507 - 507
  • [39] Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration
    Ge, Qunfang
    Wang, Yi
    Zhu, Huiling
    Xu, Kaihong
    Sheng, Lixia
    Yan, Xiaoyan
    Ouyang, Guifang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [40] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
12345